One major issue ofnewborn screening for congenital adrenal hyperplasia due to 21-hydroxylase deficiency (21OHD) is the high false-positive rate, especially in preterm neonates.
Urinary steroid metabolite analysis using gas chromatography–mass spectrometry (GC–MS) is suitable as a confirmatory diagnostic tool.
We have developed reference values for diagnostic urinary steroid metabolite ratios in a large cohort of neonates and infants with 21OHD.
The best diagnostic ratio for 21OHD was pregnanetriolone to 6α-hydroxy-tetrahydrocortisone.